HOMA-IR
Clinical uses and interpretation of HOMA-IR?
HOMA-IR is a simple surrogate marker used to estimate insulin resistance, calculated from fasting glucose and fasting insulin.
✅ Normal Values and Interpretation
There is no universal cut-off. Cutoffs vary by population, ethnicity, and assay used.
But clinical practice generally uses:
HOMA-IR Value Interpretation
< 1.0. Excellent insulin sensitivity
1.0 – 1.9. Normal insulin sensitivity
2.0 – 2.5 Early insulin resistance
2.5 – 3.9. Moderate insulin resistance
≥ 4.0 Severe insulin resistance / hyperinsulinemic state
For South Asian / Middle Eastern populations, even HOMA-IR > 2.0 already suggests significant insulin resistance.
Clinical Uses of HOMA-IR
HOMA-IR is most useful for:
1) Diagnosing insulin resistance
Especially in:
Obesity
Metabolic syndrome
Acanthosis nigricans
PCOS
Pre-diabetes
NAFLD / NASH
Because fasting glucose may be normal in these conditions, but fasting insulin is already high.
2) Risk Stratification
High HOMA-IR predicts:
Type 2 diabetes
Cardiovascular disease
Fatty liver disease progression
PCOS severity
Increased triglycerides
Higher uric acid
3) Monitoring response to therapy
HOMA-IR decreases with:
Weight loss
Exercise
Metformin
GLP-1 agonists (semaglutide, liraglutide)
SGLT-2 inhibitors
Low-carb / Mediterranean diets
Useful for follow-up every 3–6 months.
4) In PCOS
HOMA-IR is widely used to assess:
Severity of insulin resistance
Predict response to metformin
Reproductive outcomes
Cutoff: > 2.5 = IR in PCOS.
5) In Fatty Liver (NAFLD/NASH)
HOMA-IR strongly correlates with:
Fat deposition in the liver
Fibrosis progression
Cutoff often used: > 2.0
When NOT to use HOMA-IR
HOMA-IR is unreliable in:
Type 1 diabetes
Patients on insulin therapy
Elevated fasting glucose > 180 mg/dL
Acute illness
Pregnancy (use HOMA2 or clamps instead)

Comments
Post a Comment
Drop your thoughts here, we would love to hear from you